CA2078545A1 - Polypeptides de l'enveloppe de vih - Google Patents

Polypeptides de l'enveloppe de vih

Info

Publication number
CA2078545A1
CA2078545A1 CA002078545A CA2078545A CA2078545A1 CA 2078545 A1 CA2078545 A1 CA 2078545A1 CA 002078545 A CA002078545 A CA 002078545A CA 2078545 A CA2078545 A CA 2078545A CA 2078545 A1 CA2078545 A1 CA 2078545A1
Authority
CA
Canada
Prior art keywords
residues
amino acid
antibody
thr
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002078545A
Other languages
English (en)
Inventor
Timothy J. Gregory
Cordelia K. Leonard
Michael W. Spellman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2078545A1 publication Critical patent/CA2078545A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA002078545A 1990-04-03 1991-04-01 Polypeptides de l'enveloppe de vih Abandoned CA2078545A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50477290A 1990-04-03 1990-04-03
US07/504,772 1990-04-03

Publications (1)

Publication Number Publication Date
CA2078545A1 true CA2078545A1 (fr) 1991-10-04

Family

ID=24007676

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002078545A Abandoned CA2078545A1 (fr) 1990-04-03 1991-04-01 Polypeptides de l'enveloppe de vih

Country Status (5)

Country Link
EP (1) EP0527789A1 (fr)
JP (1) JPH05506221A (fr)
AU (1) AU7676891A (fr)
CA (1) CA2078545A1 (fr)
WO (1) WO1991015512A2 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE238065T1 (de) * 1990-09-27 2003-05-15 Tripep Ab Peptide zur verwendung in impfung und anregung von antikörperbildung gegen menschliches immunschwäche virus
CA2114849C (fr) * 1991-08-29 2007-04-24 Jay A. Berzofsky Antigenes peptidiques multideterminants qui stimulent la reponse des lymphocytes t auxiliaires contre le hiv chez une gamme de sujets humains
US5869624A (en) * 1993-03-26 1999-02-09 Progenics Pharmaceuticals, Inc. HIV-1 vaccines, antibody compositions related thereto, and therapeutic and prophylactic uses thereof
EP0708659A4 (fr) * 1993-06-07 2000-08-23 Genentech Inc Polypeptides d'enveloppe du vih
DE4405810A1 (de) 1994-02-23 1995-08-24 Behringwerke Ag Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung
US6585979B1 (en) 1996-07-08 2003-07-01 Genentech, Inc. HIV envelope polypeptides and immunogenic composition
ZA975889B (en) * 1996-07-08 1998-02-23 Genentech Inc HIV envelope polypeptides and vaccine.
GB9615533D0 (en) * 1996-07-24 1996-09-04 Peptide Therapeutics Ltd Diagnostic test for herpes simplex virus type-2
US6271198B1 (en) 1996-11-06 2001-08-07 Genentech, Inc. Constrained helical peptides and methods of making same
EP0938497B1 (fr) * 1996-11-06 2007-02-28 Genentech, Inc. Peptide a structure helicoidale contrainte et leurs procedes de fabrication
AU2487300A (en) 1998-12-31 2000-07-31 Chiron Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
WO2000039302A2 (fr) 1998-12-31 2000-07-06 Chiron Corporation Expression amelioree de polypeptides hiv et production de particules de type viral
ES2299276T3 (es) 1998-12-31 2008-05-16 Novartis Vaccines And Diagnostics, Inc. Polipeptidos env del vih modificados.
AU2002320314A1 (en) 2001-07-05 2003-01-21 Chiron, Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
US20030170614A1 (en) 2001-08-31 2003-09-11 Megede Jan Zur Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
US8715685B2 (en) * 2009-07-14 2014-05-06 Lucia Irene Gonzalez Stereoisomer peptides and their polymer conjugates for HIV disease
CN118666955B (zh) * 2024-05-30 2025-11-18 吉林大学 一种以多肽为配体的金纳米簇及甲基对硫磷的检测方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2102347T3 (es) * 1987-02-20 1997-08-01 Genentech Inc Metodos y composiciones para la utilizacion de polipeptidos env y anticuerpos anti-env de hiv.
AU2914889A (en) * 1987-08-28 1989-04-17 Board Of Regents, The University Of Texas System Prophylaxis and therapy of acquired immunodeficiency syndrome
SE8704185L (sv) * 1987-10-28 1989-04-29 Ferring Ab Nya peptider, artificiella antigener och immunoanalystestsatser
WO1989005821A1 (fr) * 1987-12-21 1989-06-29 Arch Development Corporation Antigenes et anticorps associes au virus d'immunodeficience humaine
AU629528B2 (en) * 1988-01-27 1992-10-08 Biochem Pharma Inc. Synthetic peptides and mixtures thereof for detecting hiv antibodies
CA1341285C (fr) * 1988-02-12 2001-08-14 Chang Yi Wang Peptides synthetiques servant a la detection d'anticorps de la proteine de surface gp120 du virus hiv, destines au diagnostic du sida, ainsi que d'etats pre-sidatiques, ou aux fins de vaccins

Also Published As

Publication number Publication date
EP0527789A1 (fr) 1993-02-24
WO1991015512A2 (fr) 1991-10-17
WO1991015512A3 (fr) 1991-12-12
JPH05506221A (ja) 1993-09-16
AU7676891A (en) 1991-10-30

Similar Documents

Publication Publication Date Title
AU647108B2 (en) Methods and compositions for vaccination against HIV
US6815201B2 (en) HIV-1 gp120 V1/V2 domain epitopes capable of generating neutralizing antibodies
ES2121733T5 (es) Variantes de adhesiones, acido nucleico que las codifica asi como composiciones que las contienen.
US6335017B1 (en) Compositions and methods for treating viral infections
CA2078545A1 (fr) Polypeptides de l'enveloppe de vih
EP0693937B1 (fr) Vaccins derives de vih-1, compositions d'anticorps correspondantes et leur utilisation therapeutique et prophylactique
EP0279688B1 (fr) Méthodes et compositions pour l'utilisation de polypeptides env et anticorps anti-env de HIV
US7041293B1 (en) HIV env antibodies
US5614612A (en) Purified gp120 compositions retaining natural conformation
PL155084B1 (en) A method of monoclonic antibodies generating and the useof theses antibodies in distributions based on immulogical affinity
Berman et al. Expression and immunogenicity of the extracellular domain of the human immunodeficiency virus type 1 envelope glycoprotein, gp160
EP1016671A2 (fr) Anticorps monoclonaux humains contre la glycoprotéine transmembranaire (gp41) de HIV-1, et peptides associés
WO1998041536A1 (fr) Glycoproteines enveloppes de vih et vis a glycosylation deficiente
AP502A (en) Multiple branch peptide constructions for use against HIV.
EP1011707B1 (fr) EPITOPES DU DOMAINE V1/V2 gp120 DU VIH-1, CAPABLES DE PRODUIRE DES ANTICORPS NEUTRALISANTS
JP3364181B2 (ja) ヒト免疫不全ウイルスのエンベロープポリペプチドおよびその抗体
AU2008203501A1 (en) Compositions and methods for treating viral infections
MXPA99003380A (en) Compositions and methods for treating viral infections

Legal Events

Date Code Title Description
FZDE Discontinued